Tobacco Smoke Exposure Limits the Therapeutic Benefit of Tezacaftor/Ivacaftor in Pediatric Patients with Cystic Fibrosis

OBJECTIVES: Tobacco smoke exposure reduces CFTR functional expression in vitro and contributes to acquired CFTR dysfunction. We investigated whether it also inhibits the clinical benefit of CFTR modulators, focusing on tezacaftor/ivacaftor, approved in February 2018 for individuals with CF age ≥12 y...

Full description

Saved in:
Bibliographic Details
Published in:J Cyst Fibros
Main Authors: Baker, Elizabeth, Harris, William T., Rowe, Steven M., Rutland, Sarah B., Oates, Gabriela R.
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018981/
https://ncbi.nlm.nih.gov/pubmed/33023836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcf.2020.09.011
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items